Pacific Edge poised for US$1.2 billion opportunity

Pacific Edge poised for US$1.2 billion opportunity
Brent Melville
Chris Gallaher, chair of Pacific Edge, described the six months through September as a step-change for the firm, when revenue grew and losses narrowed as the cancer diagnostics company scales up to meet burgeoning US and global demand for its cancer detection testing.That included a two-month contribution from the US Centers for Medicare and Medicaid Services - CMS - including the Cxbladder for local coverage, which saw operating revenue in that market jump 46 percent to $2.9 million from the same period a year earlier.CMS-related testing acros...

More Listed Companies

How ‘shareholder value’ became a Wall Street mantra
Policy

How ‘shareholder value’ became a Wall Street mantra

Michael Jensen inspired the transformation of capitalism. Was he a hero or a villain?

Bloomberg 13 Apr 2024
How many boards should a director sit on?
Listed Companies

Simon Robertson: How many boards should a director sit on?

An attempt to judge the composition trends in NZX boards is challenging.

Simon Robertson 13 Apr 2024
Wellington council picks Precinct for major civic square project
Property

Wellington council picks Precinct for major civic square project

Firm will fund and build the new five-star green building.

Staff reporters 11 Apr 2024
Numbers and letters for investors
Markets

Simon Robertson: Numbers and letters for investors

A plea for standardised financial reporting from NZX-listed companies.

Simon Robertson 02 Mar 2024